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Abstract  
Paclitaxel is a current standard chemotherapeutic drug for ovarian cancer with several 
side effects. Recurrences of drug resistant clones have been considered the serious 
problem in the failure of chemotherapy. Medicinal marine natural products have been 
intensively proposed as diverse chemotherapeutic agents. Therefore there is an affinity 
to find efficient modality to overwhelm ovarian cancer chemo resistance complication. 
Here we examine whether brittle star extract as marine echinoderm natural resources 
can remarkably improve the cytotoxicity of paclitaxel in human ovarian cancer. MTT 
(dimethyl thiazol-2-yl]-2, 5-diphenyl tetrazolium bromide) assay, PI (Propodium 
Iodide) assay, DAPI (4', 6-diamidino-2-phenylindole) staining, Acridine orange 
staining, caspase-3 and caspase-9 were performed to investigate cytotoxic effect. We 
found that a combination of sub-toxic concentrations of brittle star methanolic extract 
(lower than IC50) can significantly enhance ovarian cell growth inhibition and intrinsic 
apoptosis pathways induced by paclitaxel. Consequently a combination of paclitaxel 
and brittle star extract may offer novel innovative strategies for ovarian cancer 
chemotherapy. 
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Introduction  
Ovarian cancer is a gynecological 
malignancy and one of the most leading 
causes of women mortality worldwide 
for which few etiological factors 
involved have been identified (Leung, 
2013). There are several therapeutic 
strategies to ovarian cancer therapy; 
however the first line of treatment is a 
combination of surgery with platinum 
based chemotherapy (Kim et al., 2013). 
Also, secondary cyto reductive surgery 
and combination chemotherapies such 
as carboplatin/paclitaxel and 
cisplatin/docetaxel have been proposed 
as main treatment options (Ingersoll et 
al., 2009). Chemotherapy has been used 
as a common therapeutic route due to 
the higher incidence of ovarian 
neoplastics in advanced stages III, and 
IV (Rutherford, 2013).  Paclitaxel 
(taxol) as mainly plant derived agents 
are natural anticancer drugs, tubulin 
binding agents, antimitotic drugs and 
cell inducing apoptosis agents that are 
approved as anti-tumor drugs against 
ovarian cancer (Lee et al., 2012). 
However, acquisition of chemo 
resistance is the main obstacle of 
conventional ovarian cancer modality, 
therefore development of efficient 
alternatives against chemo resistance is 
appreciable in ovarian cancer treatment 
(Caruso and Tomao, 2013). Growing 
body of research have attempted to 
augment the worth of paclitaxel based 
therapy by the simultaneous 
administration of natural cytotoxic 
substances ( Malik et al., 2011).  
     Natural products are rich sources of 
novel biomedicine compounds with 
numerous chemical diversity from 
terrestrial and marine ecosystems 
reflecting conservation of self-defense 
mechanism against predators, resisting 
environmental stress and acting as 
signaling molecules (Demain and 
Vaishnav, 2011). The safety, low 
toxicity and few side effects of natural 
products candidate them as 
chemotherapeutic drugs. Today, many 
anti-neoplastic drugs such as 
vincristine, vinblastine,  irinotecan, 
etoposide and paclitaxel have been 
evolved from herbal resources (Fiona 
and Saunders, 2010).   
     Marine environments represent a 
rich source of efficient anti-cancer 
agents, so as in this regard, the 
application of marine natural products 
have received much attention due to 
their tremendous structural diversity in 
oncological approaches (Gerwick and 
Moore, 2012). Didemnin B, aplidine, 
bryostatn, citirabine, dolastatin and 
ecteinascidian (ET-743) are examples 
of marine derived agents that are being 
applied as anticancer leads ( Haefner, 
2003). Hence, introducing of valuable 
marine antitumor agents can suggest 
attractive insight to fighting cancer. 
One critical approach to discover new 
chemotherapeutic agents is the 
evaluation of anticancer effects of total 
natural extracts to obtain biomedicinal 
properties ( Dhorajiya et al., 2012).  
     Brittle stars are extensive marine 
invertebrates and possess some 
bioactive metabolites, including 
glycosides, terpenes, naphtaquinone and 
cerebrosides which may be appreciable 
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in anti-cancer therapy (Weihong et al., 
2004). 
     Given the lack of scientific 
information to confer the utilization of 
marine natural fauna in the ovarian 
cancer treatment and loss of adequate 
knowledge related to biomedical 
properties of ophiuroidae prompted us 
to evaluate the cytotoxic effect of the  
Persian Gulf brittle star (Ophiocoma 
erinaceus) as a frequent marine 
echinoderm in the Persian Gulf. 
 
Materials and methods 
Chemicals and reagents 
A2780CP human ovarian cancer cells 
were purchased from NCBI (National 
Cell Bank of Iran). RPMI 1640 
Medium, FBS (Fetal Bovine Serum), 
trypsin-EDTA and antibiotic 
(Penicillin-Streptomycin) were obtained 
from Gibco-USA. Taxol (paclitaxel) 
was purchased from Sigma-USA. MTT 
(3-[4,5- dimethyl thiazol-2-yl]-2,5-
diphenyl tetrazolium bromide) and 
DAPI was prepared from Applichem 
(USA). PI (propodium iodide) and 
Acridine orange was obtained from 
Sigma (USA). Caspase-3 and caspase-9 
colorimetric assay kits were purchased 
from Abcam (England). Specimens of 
the brittle star (bs, Ophiocoma 
erinaceus) were obtained from rocky 
intertidal flats of the Persian Gulf 
waters. Methanol was purchased from 
Merck (Germany). This experiment was 
performed at Research Center of 
Applied Biology of Mashhad Branch of 
the Islamic Azad University in 2013. 
 
Preparation of brittle star methanol 
extract  
The collected specimens of Ophiocoma 
erinaceus brittle star obtained from 
rocky intertidal flats of Qeshm Island 
were washed and stored at −80°C. For 
extract preparation, brittle star samples 
(about 20 g) were dried, girded and 
soaked in 200 mL methanol. Then, the 
extract was constantly stirred (72 h) to 
room temperature, filtered through an 
11 µm Whatman filter, concentrated 
under a vacuum evaporator and stored 
in −20°C. To prepare the stock solution 
(100 mg/mL) a concentrated extract 
was dissolved in DMSO. For use in the 
experiments, the stock was diluted with 
serum-free cell culture medium (RPMI 
1640) to reduce cytotoxicity of DMSO, 
so that the final concentrations of 
DMSO did not exceed 0.05%. 
 
Cell line 
A2780CP (human epithelial ovarian 
carcinoma) was purchased from the 
Pasture Institute of Tehran, Iran and 
were grown in RPMI medium 
supplemented with 10% FBS and 1% 
penicillin-streptomycin in a humidified 
incubator containing 5% CO2 at 37 °C. 
 
MTT assay 
Cytotoxic effect of the methanolic 
brittle star extract and taxol on 
A2780cp cancer cells was evaluated by 
3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) 
assay. The cancer cells were plated at a 
concentration of 10
4
 cells/well in 96-
well plates and adhered overnight. 
Then, the medium was removed and 
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incubated with different concentrations 
of methanol extract brittle star (0, 25, 
50, 100, 200 µg/mL) and taxol (0, 10, 
20, 40 µgmL
-1
). After treatment, 20 μL 
of MTT stock solution (5 mgmL
-1
 in 
PBS) was added to each well and the 
plates were further incubated for 4hr at 
37°C. Then MTT solution was 
discarded and100 μL of DMSO was 
added to each well and the absorbance 
was measured at 570 nm using micro 
plate reader (Epoch, USA). 
 
Cell morphological observation 
In order to investigate the cytotoxic 
effects of brittle star methanolic extract 
and taxol on cell morphology,  
A2780cp cells were plated in 24 well 
culture plates (10
5
 cells/well) in RPMI 
1640 supplemented with 10% FBS. 
After 24 h adherence of cells, treatment 
was performed at a defined 
concentration. After 24 h, the cells were 
examined under inverted microscope 
(Bio Photonic, Brazil). 
 
Acridine orange/ propodium iodide 
staining and DAPI staining 
The cultured cells in 6 well plates were 
treated with defined concentrations of 
brittle star methanolic extract and taxol 
for 24 h, harvested and stained with 10 
µL (100 µgmL
-1
 Acridine orange and 
100µg/mL propodium iodide mixture). 
For DAPI staining, A2780cp cells were 
cultured on a coverslip, and then 
incubated with desired concentrations 
of brittle star methanolic extract and 
taxol for 24 h. Then the cells were fixed 
with methanol for 5 min and exposed to 
100 µg/mL DAPI for 15 min at 37°C in 
the dark. Eventually, cells were 
visualized under a fluorescence 
microscope.  
 
Analysis of cell death 
To find out the apoptotic effect of 
methanol extract, brittle star and taxol 
cultivated A2780cp cells were 
incubated with medium containing 
concentrations of brittle star extract and 
taxol overnight. Then the cells were 
washed with PBS and resuspended with 
propidium iodide (PI; Sigma) 
containing 0.1% sodium citrate plus 
0.1% Triton X100 at 37°C for 30 min 
and then placed at 4°C in the dark for 
10 min and the apoptosis analysis was 
evaluated using a FACScan laser flow 
cytometer (FACSCalibur, Becton 
Dickinson, USA). 
 
Measurement of caspase-3 and -9 
activity assay 
Colorimetric caspase-3 and -9 assay kits 
were utilized for the measurement of 
enzymatic activities on the basis of 
cleavage of p-nitroaniline (pNA) from 
labeled substrate DEVD-pNA and p-
nitroanilide (pNA) from labeled 
substrate LEHD-p-NA by active 
enzyme. Briefly, 3×10
6
 plated cells 
were incubated for 24h with appropriate 
concentrations of brittle star methanolic 
extract and taxol. Then, treated cells 
were trypsinized and incubated with 
300µL lysis buffer for 10 min on ice 
and centrifuged at 4C to obtain a rich 
supernatant from cytosolic protein 
content. The lysate was examined for 
measurement of caspase 3 and caspase 
9 activities according to the 
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manufacture’s protocol. Absorbance of 
chromophore p-NA was determined 
spectrophotometerically at 405 nm 
(Epoch, USA). 
 
Statistical analysis  
The statistical analysis carried out by 
SPSS software, ANOVA, and Student’s 
t test. All results were expressed as 
mean±SE and the level of p≤0.05 was 
considered significant. 
 
Results 
Morphological observations under 
treatment with bs extract and taxol The 
morphology of A2780cp cells were 
studied under inverted microscopy.  
The photomicrographs showed that 
ovarian cancer cells indicated typical 
characteristics of apoptosis in response 
to bs methanolic extract and paclitaxel 
treatment in a dose dependent manner. 
Meanwhile, bs extract did not induce 
significant cytotoxicity on A2780cp 
cells under exposure with 5% DMSO. 
The figures were taken from IC50 
concentration (Fig. 1). 
 
Bs extract enhances the cytotoxic effect 
of paclitaxel on ovarian cancer cells 
The cell cytotoxicity of combination 
treatment of bs extract and taxol was 
evaluated by MTT assay. 
 
 
Figure1: Effects of bs extract and taxol on morphology of A2780cp ovarian cancer cells. Images 
were taken with 400 magnifications. A) Control (without treatment) B) bs methanolic 
extract (50 µgmL
-1
) C) taxol (20 µgmL
-1
) D) synergism effects of bs extract (25 µgmL
-1
) 
and taxol (10 µgmL
-1
). All concentrations were diluted with medium. 
 
As exhibited in Fig. 2, bs extract and 
paclitaxel noticeably attenuated the cell 
viability of A2780cp cancer cells in a 
dose dependent manner.  
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Figure 2: The effect of Brittle star alcoholic extract, taxol and co-treatment on cell viability of 
A2780cp cell line at 48h treatment period as compared to untreated cells using MTT 
assay. Data represented as Mean±SEM. ***p<0.001 were considered significant 
between experimental groups and control. 
 
 
The cell survival was 50.5, 51.1 and 
49.4 following treatment with 50 µgmL-1 
bs, 20 µg/mL taxol and 10 µgmL-1 taxol 
and 25 µg/mL bs (synergistic treatment) 
for 48h, respectively. IC50 value was 
determined as 49.2 µgmL
-1
 (bs 
treatment) and 18.4 µg/mL (taxol 
treatment) (Fig. 2). 
Apoptosis detection by DAPI staining  
Apoptosis is programmed cell suicide 
that is distinguished by multiple 
morphological alterations such as 
chromatin condensation, nuclear 
fragmentation, cytoplasmic blebbing 
and apaptosome formation. DAPI is a 
fluorescence stain that creates 
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fluorescent complex with double strand 
DNA that is applied for apoptotic 
detection. As shown in Fig. 3, ovarian 
cancer cells treated with bs extract or 
taxol or combination treatment with 
lower concentration of IC50 of each 
alone, have revealed chromatin 
gathering that is considered one of the 
main features of apoptosis (Fig. 3). 
 
 
Figure 3: Fluorescence micrographs of bs extract and taxol on A2780cp cells that indicated nuclear 
fragmentation. A) untreated cells, B) 50µgmL-1 Bs extract treatment, C) 20 µgmL-1 
paclitaxel treatment, D)  combination treatment of Bs extract and taxol. 
 
Morphological characterization of 
apoptosis by AO/PI staining 
To examine apoptotic induction under 
treatment with bs extract and paclitaxel, 
the A2780cp cells were stained with 
Acridine orange/propodium iodide. 
This method recognizes alive, apoptotic 
and necrotic cells so that green color, 
bright green color, orang color and red 
color are characterized as live, early 
apoptotic, late apoptotic and necrotic 
cells, respectively. As exhibited in 
figure 4, treated ovarian cancer cells 
displayed augment of cell permeability 
compared with untreated cells. 
Therefore, anti proliferative effects of 
bs extract and paclitaxel would be 
attributed with apoptosis induction of 
ovarian cancer cells (Fig. 4). 
 
Flow cytometry analysis for apoptosis 
detection  
PI staining to evaluate cell membrane 
integrity of treated ovarian cancer cells 
with paclitaxel or bs extract or synergic 
effects indicated sub-G1 peak 
demonstrated in apoptotic cells 
following DNA fragmentation. Flow 
cytometry histogram of treated cells 
revealed apoptosis cell death in cell 
induced cytotoxicity (Fig. 5). 
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Figure 4: Fluorescence images of acridine orange / propodium iodide stained ovarian cancer cells 
treated with bs extract and paclitaxel. A) Control group with normal structure, B) 
treatment with IC50 of bs extract, C) treatment with taxol and D) synergism treatment 
with paclitaxel and bs extract. 
 
 
Figure 5: Apoptotic effect of Brittle star alcoholic extract and paclitaxel treatment of the ovarian 
cancer cells by flow cytometry analysis. Flow cytometry histogram of treated A2780cp 
cells indicated sub-G1 peak as hallmark of apoptotic cell death. 
A B 
C D 
A B 
C D 
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Figure 6: Bs alcoholic extract and paclitaxel induced activation of caspase-3 and caspase-9 in 
A2780cp cells. p<0.05 were considered significant between experimental groups and 
control. 
 
Discussion 
Standard chemotherapeutic strategies 
for the treatment of ovarian cancer are 
comprised of paclitaxel and platinum 
based drug combinations (Zhu et al., 
2005). Taxol is a  diterpene ester and 
apoptosis inducing drug  that is 
currently utilized as a drug in ovarian 
cancer (Meshkini and Yazdanparast, 
2012). Significant attention has been 
recently concentrated to distinguish  
naturally occurring anti-carcinogenic 
metabolites from marine organisms but 
investigation on the therapeutic effect 
of brittle star is less evident (Blunt et 
al., 2012). In the present study, we 
aimed to compare the anti-cancer 
effects of brittle star methanolic extract 
with common chemotherapeutic drug 
paclitaxel. As revealed in our data, 
brittle star methanolic extract exhibited 
a dose dependent cytotoxic effect 
against human ovarian A2780CP cells 
and enhanced chemo sensitivity of 
A2780CP ovarian cancer cells 
synergistically with paclitaxel. 
Importantly, the combination of brittle 
star methanolic extract and taxol 
induced apoptosis cell death which can 
be an appropriate adjuvant for ovarian 
cancer therapy.  
     Substantial evidence exhibits that 
natural products possess considerable 
cytotoxicity against ovarian cancer cells 
(Zhu et al., 2005). For example, 
Shosaikoto is a mixture of seven plant 
extracts (Bupleurum root, Pinellia 
tuber, Scutellaria root, Jujube fruit, 
Gingseng root, Glycyrrhiza root, and 
Ginger rhizome) that have been utilized 
as treatment options against ovarian 
cancer in Chinese traditional medicine 
(Silva et al., 2003). Methanol extracts 
from the root bark of Hymenocardia 
acida, Methanol extracts from the stem 
bark of Mangifera indica , Methanol 
extracts from the leaves of Sida 
rhombifolia, and the aqueous extract of 
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Cinnamomum cassia have been 
considered potent medicinal herbal 
extract inhibitors of ovarian neoplasia 
(Silva et al., 2003). The literature 
survey identified many chemically 
defined compounds isolated from 
nature in different stages of 
investigations for ovarian cancer 
treatment of which the most promising 
agents attributed to alkaloids ( Kumaran 
et al., 2009).     
     The major objective of anti-tumor 
therapy is finding bioactive substances 
which suppress the proliferation of 
ovarian tumor cells merely. 
Ecteinnascidin (ET-743) is a tetra hydro 
iso quinoline alkaloid extracted from 
the Carrabine tunicate applied as a 
potent drug against ovarian carcinoma 
xenografts as being more officious 
compared with cis-platinum. 
mycalamide A and B, heterocyclic 
compounds isolated from Mycale sp. 
and Theonella sp. sponges that are 
efficient against M5076 ovarian 
sarcoma (Valoti et al., 1998). 
     An in vitro study by Powell et al 
(2003) reported that a water extract of 
Scutellaria barbatae  administrated to 
ovarian cancer cells, inhibited cancer 
cell growth and induced ovarian cancer 
cell apoptosis (Powell et al., 2003). 
Moreover, Rhode et al (2007) 
suggested that ginger (Zingiber 
officinale Rosc) possesses anti-
carcinogenic properties against ovarian 
cancer with NF-ƙB suppression and 
VEGF, IL-8 diminishing (Rhode et al., 
2007). Based on reports carried out by 
Ooi, Physalis minima whole extracts 
can induce apoptotic and autophagy cell 
death in Caov-3 ovarian cancer cells 
that are characterized by DNA 
fragmentation, analysis of mRNA 
expression of p53, c-myc, caspase-3 
and ultra-structural changes in TEM 
analysis which can be valuable as new 
anti-cancer sources in ovarian cancer 
therapy (Leong et al., 2010). 
     One of the major complications 
correlated with ovarian cancer therapy 
is drug resistance and the evasion of 
apoptosis accounting for crucial factors 
for anti-neoplastic drug resistance.  It 
assumes that the combination of two or 
more drugs is more effective than a 
single agent therapy in the process of 
ovarian chemotherapy and 
overwhelming to ovarian cancer 
chemo-resistance (Wender et al., 2012). 
For instance the application of 
carboplatin with paclitaxel approved 
standard regimen for advanced or 
recurrent ovarian cancer. Zhang et al 
evaluated the co-administration of 
tetrandrine (a bis benzyl isoquinoline 
alkaloid, extracted from the root of the 
Stephania tetrandrinerandra) with 
cisplatin to overcome drug resistance in 
ovarian cancer treatment. Their findings 
indicated that the mixture of tetrandrine 
with cisplatin enhanced the rate of 
apoptosis and induced higher anti-
tumor activities than each drug alone, 
consequently tetrandrine can utilize 
appropriate candidates as adjunct to 
improve ovarian cancer chemotherapy 
(Zhang et al., 2011).  
     Sun et al. (2011) examined the 
combination of perifosine (an oral alkyl 
phospholipid) with paclitaxel as a 
chemotherapeutic option for ovarian 
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cancer and concluded that the 
synergistical application of perifosine 
and paclitaxel with suppression of 
AKT/mTOR complex 1, elevation of 
reactive oxygen species generation and 
activation of AMPK, JNK, caspase3 
increased sensitization of ovarian 
cancer cells to apoptosis, so this 
modality may be valuable in ovarian 
cancer therapeutics (Sun et al., 2011).  
     Tie et al designed an investigation 
on the anti-cancer effects of aqueous 
and organic Devil’s club Oplopanax 
horridus root bark extracts on sensitive 
and resistant ovarian cancer cells and 
concluded that this plant extract 
possesses cytotoxic effects against 
cisplatin sensitive and resistant cancer 
lines and at low dosage induced 
apoptosis with S, G2/M cell cycle arrest 
that can be proposed as an appropriate 
ovarian anti-cancer candidate (Tai et 
al., 2010).    
     Yu (2013) conducted an 
investigation on the anti-cancer 
properties of Rauwolfia vomitoria plant 
extract along with carboplatin to assess 
the efficacy of chemotherapy. Their 
results showed that Rauwolfia 
vomitoria extract inhibited ovarian 
cancer cells proliferation dose 
dependently with apoptosis induction. 
Besides, the combination of the extract 
with carboplatin was more effective 
because of diminished tumor size and 
ascite volume. Therefore, this array can 
be appreciable as a chemotherapeutic 
option (Yu et al., 2013). 
     A synergistic effect of whole extract 
with ovarian cancer drugs was offered 
by Tai and co-workers, who found that 
Rosmarinus officinalis extract can 
enhance the cytotoxicity of cisplatin on 
A2780 and A2780CP70 ovarian cancer 
cells by inducing apoptosis and altering  
the expression of apoptotic related 
genes. Therefore rosemary extract 
further exploited the discovery of an 
adjunct in ovarian cancer therapeutic 
(Tai et al., 2012). 
In general, the outcomes of this 
experiment for the first time 
demonstrated that the methanolic brittle 
star extract exerts precious cytotoxic 
and apoptotic effects by increasing 
caspase-3 and caspase-9 activity and 
holds as a promising adjunct to improve 
the anti-tumor efficacy of paclitaxel in 
human ovarian cancer.  
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